Kogenate

In the US, Kogenate (antihemophilic factor systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

US matches:

• Kogenate


• Kogenate FS


• Kogenate FS recombinant


• Kogenate FS with Bioset recombinant


• Kogenate FS w/BIO-SET

UK matches:

• KOGENATE Bayer 1000 IU Powder and solvent for solution for injection. (Medimop) (SPC)
• KOGENATE Bayer 2000 IU Powder and solvent for solution for injection.(Medimop) (SPC)
• KOGENATE Bayer 250 IU Powder and solvent for solution for injection (Medimop) (SPC)
• KOGENATE Bayer 3000 IU Powder and solvent for solution for injection.(Medimop) (SPC)
• KOGENATE Bayer 500 IU Powder and solvent for solution for injection (Medimop) (SPC)

Ingredient matches for Kogenate

Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Kogenate in the following countries:

• Belgium


• Canada


• Georgia


• Germany


• Hungary


• Ireland


• Italy


• Luxembourg


• New Zealand


• Portugal


• Taiwan


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.